Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 4, 2013, Pages 852-857

  Souli, Maria ^a   Galani, Irene ^a   Plachouras, Diamantis ^a   Panagea, Theofano ^a,b   Armaganidis, Apostolos ^a   Petrikkos, George ^a   Giamarellou, Helen ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AMALIA FLEMING GENERAL HOSPITAL   (Greece)

^c HYGEIA HOSPITAL   (Greece)

Author keywords

Acinetobacter; Enterobacter spp; K. Pneumoniae; Multidrug resistant; P. Aeruginosa

Indexed keywords

ALLOY; AMIKACIN; AZTREONAM; CARBAPENEMASE; CEFEPIME; CIPROFLOXACIN; COLISTIN; COPPER; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; POLYVINYLCHLORIDE; STAINLESS STEEL;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; ROOM TEMPERATURE; SURFACE PROPERTY;

ALLOYS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; COPPER; CROSS INFECTION; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS;

EID: 84875272323     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks473     Document Type: Article

References (25)

1. Grass G, Rensing C, Solioz M. Metallic copper as an antimicrobial surface. Appl Environ Microbiol 2011; 77: 1541-7.
2. US Environmental Protection Agency. http://www.epa.gov/pesticides/ factsheets/copper-alloy-products.htm (20 August 2012, date last accessed).
3. Espirito Santo C, Lam EW, Elowsky CG et al. Bacterial killing by dry metallic copper surfaces. Appl Environ Microbiol 2011; 77: 794-802.
4. Espirito Santo C, Taudte N, Nies DH et al. Contribution of copper ion resistance to survival of Escherichia coli on metallic copper surfaces. Appl Environ Microbiol 2008; 74: 977-86.
5. Warnes SL, Green SM, Michels HT et al. Biocidal efficacy of copper alloys against pathogenic enterococci involves degradation of genomic and plasmid DNA. Appl Environ Microbiol 2010; 76: 5390-401.
6. Carmeli Y, Akova M, Cornaglia G et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010; 16: 102-11.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA, 2011.
8. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 2.0, 2012-01-01. http://www.eucast.org/clinical_ breakpoints (20 August 2012, date last accessed).
9. Lee K, Chong Y, Shin HB et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-b-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001; 7: 88-91.
10. Tsakris A, Kristo I, Poulou A et al. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae in the clinical laboratory. J Clin Microbiol 2009; 47: 362-7.
11. Koratzanis E, Souli M, Galani I et al. Epidemiology and molecular characterisation of metallo-b-lactamase-producing Enterobacteriaceae in a university hospital intensive care unit in Greece. Int J Antimicrob Agents 2011; 38: 390-7.
12. Souli M, Galani I, Antoniadou A et al. An outbreak of infection due to b-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010; 50: 364-73.
13. Woodford N, Ellington MJ, Coelho JM et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351-3.
14. Wheeldon LJ, Worthington T, Lambert PA et al. Antimicrobial efficacy of copper surfaces against spores and vegetative cells of Clostridium difficile: the germination theory. J Antimicrob Chemother 2008; 62: 522-5.
15. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-8.
16. Siegel JD, Rhinehart E, Jackson M et al. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007; 35 Suppl 2: S165-93.
17. Schmidt MG, Attaway HH, Sharpe PA et al. Sustained reduction of microbial burden on common hospital surfaces through the introduction of copper. J Clin Microbiol 2012; 50: 2217-3.
18. Casey AL, Adams D, Karpenen TJ et al. Role of copper in reducing hospital environment contamination. J Hosp Infect 2010; 74: 72-7.
19. Espirito Santo C, Morais PV, Grass G. Isolation and characterization of bacteria resistant to metallic copper surfaces. Appl Environ Microbiol 2010; 76: 1341-8.
20. Elguindi J, Wagner J, Rensing C. Genes involved in copper resistance influence survival of Pseudomonas aeruginosa on copper surfaces. J Appl Microbiol 2009; 106: 1448-55.
21. Mehtar S, Wiid I, Todorov SD. The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in vitro study. J Hosp Infect 2008; 68: 45-51.
22. Michels HT, Noyce JO, Keevil CW. Effects of temperature and humidity on the efficacy of methicillin-resistant Staphylococcus aureus challenged antimicrobial materials containing silver and copper. Lett Appl Microbiol 2009; 49: 191-5.
23. Wilks SA, Michels HT, Keevil CW. The survival of Escherichia coli O157 on a range of metal surfaces. Int J Food Microbiol 2005; 105: 445-54.
24. Elguindi J, Moffitt S, Hasman H et al. Metallic copper corrosion rates, moisture content and growth medium influence survival of copper ion-resistant bacteria. Appl Microbiol Biotechnol 2011; 89: 1963-70.
25. ® Web Exclusive. November 2008; doi:10.1361/ amp1108copper.